Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+15.63%)
At close: Nov 16, 2026 · 4:00 PM EST

Elite Pharmaceuticals (ELTP) Interest & Investment Income (2009 - 2026)

Updated

Elite Pharmaceuticals' Interest & Investment Income was $219,200 in fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with $4,922 a year earlier and up 32.0% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Interest & Investment Income (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Elite Pharmaceuticals' Interest & Investment Income was $583,710 through Sep 30, 2026; for FY2026 (ended Mar 31, 2026), it was $207,857, up 892.4% from FY2025.

  • Interest & Investment Income has now increased for three consecutive fiscal years, with a five-year compound annual growth rate of 232.2% (FY2021 to FY2026).
  • In earlier fiscal years, Interest & Investment Income was $20,944 in FY2025 (+0.1%), $20,918 in FY2024 (+180.7%), $7,453 in FY2023 and $126.00 in FY2022 (-75.5%).
  • The fiscal Q2 2027 figure marks the highest quarterly Interest & Investment Income in data going back to fiscal Q4 2009.
  • The best year-over-year quarter for Interest & Investment Income over five years was fiscal Q1 2023 (growth of 207.1%); the worst was fiscal Q3 2022 (a decline of 86.7%).
  • Per Business Quant data, ELTP's Interest & Investment Income in the three fiscal quarters before Q2 2027 was $166,117 (Q1 2027), $114,791 (Q4 2026) and $83,602 (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn -
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 186.00 Mn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn -
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn -
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 67.00 Mn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn -
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn -
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn -
10 Elite Pharmaceuticals 401.23 Mn 274.64 Mn 15.99 Mn 219,200.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 219,200.00
Jun 30, 2026 166,117.00
Mar 31, 2026 114,791.00
Dec 31, 2025 83,602.00
Sep 30, 2025 4,922.00
Jun 30, 2025 4,542.00
Mar 31, 2025 4,560.00
Dec 31, 2024 5,092.00
Sep 30, 2024 5,902.00
Jun 30, 2024 5,390.00
Mar 31, 2024 4,833.00
Dec 31, 2023 5,249.00
Sep 30, 2023 7,320.00
Jun 30, 2023 3,516.00
Mar 31, 2023 7,266.00
Dec 31, 2022 15.00
Sep 30, 2022 43.00
Jun 30, 2022 129.00
Mar 31, 2022 49.00
Dec 31, 2021 13.00
API Access

Elite Pharmaceuticals Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ELTP&period=max&api_key=YOUR_API_KEY